| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/19/2004 | EP1289987B1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof |
| 05/19/2004 | EP1273575B1 Diazepane derivatives or salts thereof |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1220855B1 Anhydrous salt |
| 05/19/2004 | EP1190716B1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 05/19/2004 | EP1163523B1 Method for detecting predisposition to a venous thromboembolic disease |
| 05/19/2004 | EP1047664B1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 05/19/2004 | EP0801572B1 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 05/19/2004 | EP0726520B1 Disk array having redundant storage and methods for incrementally generating redundancy as data is written to the disk array |
| 05/19/2004 | EP0637237B1 Calcium receptor-active molecules |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | CN1498271A Potassium channel interactors protein and uses therefor |
| 05/19/2004 | CN1498218A Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 05/19/2004 | CN1498206A Biurethane derivatives |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1498102A Anti-atherosclerosis composition containing carotenoilds and method for inhibiting LDL oxidation |
| 05/19/2004 | CN1496982A Imidazoline compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150191C Aminoalkyl substituted benzodioxan derivatives |
| 05/19/2004 | CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors |
| 05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
| 05/19/2004 | CN1150175C Derivatives of 1,3,4-oxadiazolone |
| 05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
| 05/19/2004 | CN1150035C Recombination plasmid and application in disease prevention and control |
| 05/19/2004 | CN1150018C Medicine for treating tachy-arrhythmia |
| 05/19/2004 | CN1150017C Medicine for treating cardiovascular damage caused by systematic lupus erythematosus |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/19/2004 | CN1149994C Oral compositions of levosimendan |
| 05/19/2004 | CN1149987C Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CA2449540A1 Method of treating left ventricular dysfunction |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | CA2214759C Intimal hypertrophy inhibitors |
| 05/18/2004 | CA2159485C Anti-oxydant alkylaryl polyether alcohol polymers |
| 05/13/2004 | WO2004039797A1 A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
| 05/13/2004 | WO2004039796A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039453A2 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof |
| 05/13/2004 | WO2004039389A1 SELECTIVE HUMAN β3 ADRENALIN RECEPTOR AGONIST AGENT |
| 05/13/2004 | WO2004039330A2 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls |
| 05/13/2004 | WO2004039313A2 Preventing desensitization of receptors |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004017950A3 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 05/13/2004 | WO2004006931A3 Pharmaceutical compostions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2 |
| 05/13/2004 | WO2004002461A3 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003090684B1 Polymer compositions containing a macrocyclic triene compound |
| 05/13/2004 | WO2003082207A3 Volume efficient controlled release dosage form |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003015695B1 Canine cardiac diet |
| 05/13/2004 | WO2003006950B1 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 05/13/2004 | WO2002102804A8 New use of specific cyclolignans |
| 05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
| 05/13/2004 | WO2002051387A8 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 05/13/2004 | US20040092771 Nitro-benzamide useful as anti-arrhythmic agent |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/13/2004 | US20040092593 Hypotensive agents; cardiovascular disorders |
| 05/13/2004 | US20040092578 Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092567 Cardiovascular disorders; hypotensive agents |
| 05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092555 Pharmaceutical compositions of a thiazolidinedione derivative and their use as antidiabetics |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092525 Pirazino(aza)indole derivatives |
| 05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
| 05/13/2004 | US20040092523 Method for the treatment of heart failure |
| 05/13/2004 | US20040092519 New treatment for hot flashes |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |